189 related articles for article (PubMed ID: 8610164)
21. Stimulator cell type influences the response of T cells to staphylococcal enterotoxins.
Yagi J; Uchiyama T; Janeway CA
J Immunol; 1994 Feb; 152(3):1154-62. PubMed ID: 7905498
[TBL] [Abstract][Full Text] [Related]
22. Antibodies are capable of directing superantigen-mediated T cell killing of chronic B lymphocytic leukemia cells.
Gidlöf C; Dohlsten M; Kalland T; Tötterman TH
Leukemia; 1995 Sep; 9(9):1534-42. PubMed ID: 7544852
[TBL] [Abstract][Full Text] [Related]
23. Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses.
Bhardwaj N; Young JW; Nisanian AJ; Baggers J; Steinman RM
J Exp Med; 1993 Aug; 178(2):633-42. PubMed ID: 8340760
[TBL] [Abstract][Full Text] [Related]
24. Crosslinked staphylococcal enterotoxin B stimulates CD8+ T cells only in the presence of unlinked costimulator signals.
Miethke T; Heeg K; Wahl C; Wagner H
Immunobiology; 1991 Nov; 183(5):433-50. PubMed ID: 1786991
[TBL] [Abstract][Full Text] [Related]
25. Staphylococcal enterotoxin B-specific adhesion of murine splenic T cells to a human endothelial cell line.
Kita M; Eguchi K; Kawabe Y; Tsukada T; Migita K; Kawakami A; Matsuoka N; Nagataki S
Immunology; 1996 Jul; 88(3):441-6. PubMed ID: 8774362
[TBL] [Abstract][Full Text] [Related]
26. A superantigen-antibody fusion protein for T-cell immunotherapy of human B-lineage malignancies.
Gidlöf C; Dohlsten M; Lando P; Kalland T; Sundström C; Tötterman TH
Blood; 1997 Mar; 89(6):2089-97. PubMed ID: 9058731
[TBL] [Abstract][Full Text] [Related]
27. Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity.
Lando PA; Dohlsten M; Hedlund G; Brodin T; Sansom D; Kalland T
Immunology; 1993 Oct; 80(2):236-41. PubMed ID: 7505257
[TBL] [Abstract][Full Text] [Related]
28. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
[TBL] [Abstract][Full Text] [Related]
29. Synergistic effect between CD40 and class II signals overcome the requirement for class II dimerization in superantigen-induced cytokine gene expression.
Mehindate K; al-Daccak R; Damdoumi F; Mourad W
Eur J Immunol; 1996 Sep; 26(9):2075-80. PubMed ID: 8814249
[TBL] [Abstract][Full Text] [Related]
30. Rapid clearance of the bacterial superantigen staphylococcal enterotoxin B in vivo.
Vabulas R; Bittlingmaier R; Heeg K; Wagner H; Miethke T
Infect Immun; 1996 Nov; 64(11):4567-73. PubMed ID: 8890208
[TBL] [Abstract][Full Text] [Related]
31. In vitro T cell response to staphylococcal enterotoxin B superantigen in chronic plaque type psoriasis.
Bour H; Demidem A; Garrigue JL; Krasteva M; Schmitt D; Claudy A; Nicolas JF
Acta Derm Venereol; 1995 May; 75(3):218-21. PubMed ID: 7653183
[TBL] [Abstract][Full Text] [Related]
32. Ultraviolet B-exposed major histocompatibility complex class ii positive keratinocytes and antigen-presenting cells demonstrate a differential capacity to activate T cells in the presence of staphylococcal superantigens.
Skov L; Baadsgaard O
Br J Dermatol; 1996 May; 134(5):824-30. PubMed ID: 8736320
[TBL] [Abstract][Full Text] [Related]
33. Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.
Scholl P; Diez A; Mourad W; Parsonnet J; Geha RS; Chatila T
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4210-4. PubMed ID: 2542966
[TBL] [Abstract][Full Text] [Related]
34. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro.
Seth A; Stern LJ; Ottenhoff TH; Engel I; Owen MJ; Lamb JR; Klausner RD; Wiley DC
Nature; 1994 May; 369(6478):324-7. PubMed ID: 8183371
[TBL] [Abstract][Full Text] [Related]
35. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes.
Phillips JH; Gumperz JE; Parham P; Lanier LL
Science; 1995 Apr; 268(5209):403-5. PubMed ID: 7716542
[TBL] [Abstract][Full Text] [Related]
36. In vivo responses of CD4+ and CD8+ cells to bacterial superantigens.
Herrmann T; Baschieri S; Lees RK; MacDonald HR
Eur J Immunol; 1992 Jul; 22(7):1935-8. PubMed ID: 1623932
[TBL] [Abstract][Full Text] [Related]
37. T-cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction. Differential MHC requirements for superantigen and autoantigen.
LaSalle JM; Toneguzzo F; Saadeh M; Golan DE; Taber R; Hafler DA
J Immunol; 1993 Jul; 151(2):649-57. PubMed ID: 7687620
[TBL] [Abstract][Full Text] [Related]
38. Accessory cell function of a human colonic epithelial cell line HT-29 for bacterial superantigens.
Liu ZX; Sugawara S; Hiwatashi N; Noguchi M; Rikiishi H; Kumagai K; Toyota T
Clin Exp Immunol; 1997 Jun; 108(3):384-91. PubMed ID: 9182880
[TBL] [Abstract][Full Text] [Related]
39. Multiple binding sites on the superantigen, staphylococcal enterotoxin B, imparts versatility in binding to MHC class II molecules.
Soos JM; Johnson HM
Biochem Biophys Res Commun; 1994 Jun; 201(2):596-602. PubMed ID: 8002991
[TBL] [Abstract][Full Text] [Related]
40. Persistence of zinc-binding bacterial superantigens at the surface of antigen-presenting cells contributes to the extreme potency of these superantigens as T-cell activators.
Pless DD; Ruthel G; Reinke EK; Ulrich RG; Bavari S
Infect Immun; 2005 Sep; 73(9):5358-66. PubMed ID: 16113251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
